At Kid Risk, we focus on improving children's lives by understanding, characterizing, and communicating about the real risks that children face around the world, and on empowering policy makers, parents, kids, and others to use the best available information and analytical insights as we do our best for children. We recognize that managing risks is the key to realizing the best possible futures for everyone. Learn more about our mission and organization and meet our team.
Kid Risk currently focuses its research on managing the risks associated with polioviruses (read an overview) and characterizing the benefits of global investments in measles and rubella immunization. We receive funding for our research from the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the Bill & Melinda Gates Foundation. Our research demonstrates that investments in public health save lives and money.
News - Recent polio research on the logistics of restarting oral poliovirus vaccine (OPV) after its globally-coordinated cessation shows the complexity of failing to manage risks well in the polio endgame, and motivates the need for the development of a new serotype 2 OPV strain. With all of the news about measles outbreaks, like Dr. Thompson, you may be wondering: "What will it take to end fatalities from measles?" In December 2018, Dr. Thompson received the 2018 Distinguished Risk Analyst Award from the Society for Risk Anlaysis.
Polio research - Read about our extensive research on polio and learn more about our modelig studies that help to explain continued transmission of poliovirus in Pakistan and Afghanistan including the importance of implementing proactive strategies to stop transmission, the potential for undetected circulation, and tradeoffs associated with different characteristics of the poliovirus surveillance system. We also estimated the costs of the updated costs of the Global Polio Laboratory Network and insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission as it relates to certification of wild poliovirus eradication.
June 2018 - Watch Dr. Thompson briefly discuss the economic case for eradicating polio during a workshop at the National Academy of Medicine Forum for Microbial Threats meeting on Understanding the Economics of Microbial Threats.
You can also check out our other news and learn more about our research or join our mailing list to receive press releases and/or periodic updates about our work. Thank you to all of our supporters.